Maximillian Greenwald (Yale School of Medicine) - neuropsychiatry MD-PhD student profile focused on translational psychiatry and psychedelic therapeutics

Maximillian Greenwald is an MD-PhD student in neuropsychiatry whose PhD work is in Albert Powers' lab at Yale. The profile highlights his interest in translational psychiatry with a focus on pro-neuroplastic psychoactive therapeutics, including serotonergic psychedelics, and research into non-ordinary states of consciousness. His background includes neuroscience training at Middlebury College and work in clinical research at the National Institute of Mental Health (NIMH). While at NIMH, he researched ketamine’s psychoactive and rapid-acting antidepressant effects in the Experimental Therapeutics and Pathophysiology Branch. The page also lists research output and publications, including studies examining dose-dependent effects of psychedelic use on cognitive performance and related work in neurocognitive and mental health contexts.